113 related articles for article (PubMed ID: 11719217)
1. Activated c-Abl is degraded by the ubiquitin-dependent proteasome pathway.
Echarri A; Pendergast AM
Curr Biol; 2001 Nov; 11(22):1759-65. PubMed ID: 11719217
[TBL] [Abstract][Full Text] [Related]
2. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
[TBL] [Abstract][Full Text] [Related]
3. Catalase is regulated by ubiquitination and proteosomal degradation. Role of the c-Abl and Arg tyrosine kinases.
Cao C; Leng Y; Liu X; Yi Y; Li P; Kufe D
Biochemistry; 2003 Sep; 42(35):10348-53. PubMed ID: 12950161
[TBL] [Abstract][Full Text] [Related]
4. c-Abl regulates proteasome abundance by controlling the ubiquitin-proteasomal degradation of PSMA7 subunit.
Li D; Dong Q; Tao Q; Gu J; Cui Y; Jiang X; Yuan J; Li W; Xu R; Jin Y; Li P; Weaver DT; Ma Q; Liu X; Cao C
Cell Rep; 2015 Feb; 10(4):484-96. PubMed ID: 25620702
[TBL] [Abstract][Full Text] [Related]
5. The tyrosine kinase Abl is required for Src-transforming activity in mouse fibroblasts and human breast cancer cells.
Sirvent A; Boureux A; Simon V; Leroy C; Roche S
Oncogene; 2007 Nov; 26(52):7313-23. PubMed ID: 17533370
[TBL] [Abstract][Full Text] [Related]
6. c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF.
Plattner R; Kadlec L; DeMali KA; Kazlauskas A; Pendergast AM
Genes Dev; 1999 Sep; 13(18):2400-11. PubMed ID: 10500097
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1.
Lin J; Sun T; Ji L; Deng W; Roth J; Minna J; Arlinghaus R
Oncogene; 2007 Oct; 26(49):6989-96. PubMed ID: 17486070
[TBL] [Abstract][Full Text] [Related]
8. Homo- and hetero-oligomerization of the c-Abl kinase and Abelson-interactor-1.
Fan PD; Cong F; Goff SP
Cancer Res; 2003 Feb; 63(4):873-7. PubMed ID: 12591740
[TBL] [Abstract][Full Text] [Related]
9. Functional interaction between c-Abl and the p21-activated protein kinase gamma-PAK.
Roig J; Tuazon PT; Zipfel PA; Pendergast AM; Traugh JA
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14346-51. PubMed ID: 11121037
[TBL] [Abstract][Full Text] [Related]
10. c-Abl-induced apoptosis, but not cell cycle arrest, requires mitogen-activated protein kinase kinase 6 activation.
Cong F; Goff SP
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13819-24. PubMed ID: 10570156
[TBL] [Abstract][Full Text] [Related]
11. Abl tyrosine kinase regulates endocytosis of the epidermal growth factor receptor.
Tanos B; Pendergast AM
J Biol Chem; 2006 Oct; 281(43):32714-23. PubMed ID: 16943190
[TBL] [Abstract][Full Text] [Related]
12. c-Abl phosphorylates Hdm2 at tyrosine 276 in response to DNA damage and regulates interaction with ARF.
Dias SS; Milne DM; Meek DW
Oncogene; 2006 Oct; 25(50):6666-71. PubMed ID: 16702947
[TBL] [Abstract][Full Text] [Related]
13. Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor.
Yu HH; Zisch AH; Dodelet VC; Pasquale EB
Oncogene; 2001 Jul; 20(30):3995-4006. PubMed ID: 11494128
[TBL] [Abstract][Full Text] [Related]
14. The c-Abl tyrosine kinase contributes to the transient activation of MAP kinase in cells plated on fibronectin.
Renshaw MW; Lewis JM; Schwartz MA
Oncogene; 2000 Jun; 19(28):3216-9. PubMed ID: 10918577
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
Li S; Couvillon AD; Brasher BB; Van Etten RA
EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
[TBL] [Abstract][Full Text] [Related]
16. Deregulation of proteasome function induces Abl-mediated cell death by uncoupling p130CAS and c-CrkII.
Holcomb M; Rufini A; Barilà D; Klemke RL
J Biol Chem; 2006 Feb; 281(5):2430-40. PubMed ID: 16267043
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase CK2alpha is a target for the Abl and Bcr-Abl tyrosine kinases.
Hériché JK; Chambaz EM
Oncogene; 1998 Jul; 17(1):13-8. PubMed ID: 9671309
[TBL] [Abstract][Full Text] [Related]
18. Formation of long and winding nuclear F-actin bundles by nuclear c-Abl tyrosine kinase.
Aoyama K; Yuki R; Horiike Y; Kubota S; Yamaguchi N; Morii M; Ishibashi K; Nakayama Y; Kuga T; Hashimoto Y; Tomonaga T; Yamaguchi N
Exp Cell Res; 2013 Dec; 319(20):3251-68. PubMed ID: 24041959
[TBL] [Abstract][Full Text] [Related]
19. Redox-regulated pathway of tyrosine phosphorylation underlies NF-κB induction by an atypical pathway independent of the 26S proteasome.
Cullen S; Ponnappan S; Ponnappan U
Biomolecules; 2015 Feb; 5(1):95-112. PubMed ID: 25671697
[TBL] [Abstract][Full Text] [Related]
20. En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase.
Muller AJ; Pendergast AM; Parmar K; Havlik MH; Rosenberg N; Witte ON
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3457-61. PubMed ID: 7682703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
